In endometrial cancer, combined positive expression of ATM and p53 or FANCD2 was associated with poor 5-year relapse-free survival (RFS) as compared to negative ATM/p53 or FANCD2 (68% versus 80.3%, p = 0.0241) (46). The gene discussed is ATM; the disease is endometrial cancer.